MML Investors Services
NTLA icon

MML Investors Services’s Intellia Therapeutics NTLA Stock Holding History

MML Investors Services’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,205
Closed -$970K – 2114
2021
Q4 		$970K Sell
8,205
-268
-3% -$33.6K 0.01% 1077
2021
Q3 		$1.14M Sell
8,473
-1,317
-13% -$199K 0.01% 971
2021
Q2 		$1.58M Sell
9,790
-26
-0.3% -$2.02K 0.01% 806
2021
Q1 		$788K Buy
9,816
+5,783
+143% +$388K 0.01% 1036
2020
Q4 		$219K Buy
+4,033
New +$146K ﹤0.01% 1555

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MML Investors Services's NTLA Position: Q1 2022 in Review

MML Investors Services sold out of Intellia Therapeutics (NTLA) in Q1 2022, closing a stake of 8,205 shares — an estimated $970K sold.

MML Investors Services first reported a position in NTLA in Q4 2020 and held it in 5 quarters. The position peaked at $1.58M in Q2 2021. 348 funds tracked by Wall St. Rank hold NTLA as of Q1 2022.

  • MML Investors Services reported no remaining Intellia Therapeutics position as of Q1 2022 after selling out during the quarter.
  • MML Investors Services sold 8,205 Intellia Therapeutics shares in Q1 2022, an estimated $970K.
  • MML Investors Services first reported a position in Intellia Therapeutics in Q4 2020 and held it in 5 quarters.
  • MML Investors Services's Intellia Therapeutics position peaked at $1.58M in Q2 2021.
  • 348 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2022.

Based on MML Investors Services's 13F filing for Q1 2022, filed 13 May 2022.